Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer-Reference-Cited by-同舟云学术

Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer

Published:2018-01-01 Issue:1 Volume:25 Page:576-584
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Hong Shan-Shan¹,Zhang Ming-Xing¹,Zhang Meng¹,Yu Yi¹,Chen Jun²,Zhang Xiao-Yan¹³⁴,Xu Cong-Jian¹³⁴^ORCID

Affiliation:

1. Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China;

2. Departments of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China;

3. Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai, China;

4. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, China

Funder

National Natural Sciences Foundation of China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2018.1440667

Reference38 articles.

1. Nanoparticles and targeted drug delivery in cancer therapy

2. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions

3. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration

4. Delivery of messenger RNA using poly(ethylene imine)–poly(ethylene glycol)-copolymer blends for polyplex formation: Biophysical characterization and in vitro transfection properties

5. Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5)

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy;Drug Discovery Today;2024-07

2. Follicle stimulating hormone receptor: impact of genetic variations and gene expression levels in fertility;Research Innovation Views Embryology Reproduction;2024-04-15

3. Follicle-Stimulating Hormone Receptor Expression and Its Potential Application for Theranostics in Subtypes of Ovarian Tumors: A Systematic Review;Cancers;2024-03-13

4. An Overview of Potential Applications for Nanotechnology, Probiotics, and Medicinal Plants in Infertility Problems;Current Women s Health Reviews;2023-11

5. Exosome delivery to the testes for dmrt1 suppression: A powerful tool for sex-determining gene studies;Journal of Controlled Release;2023-11